Schizoaffective Disorder

Schizoaffective disorder is a combination of symptoms of schizophrenia and mood disorder, such as depression or bipolar disorder. Symptoms may occur at the same time or at different times.

Cycles of severe symptoms are often followed by periods of improvement. Symptoms may include delusions, hallucinations, depressed episodes, and manic periods of high energy.

People with this disorder generally do best with a combination of medications and counseling.

Cluster Number:
Wiki Number: PW193
Diagnosis: Schizoaffective Disorder-Much of the Wikipedia article dealt with the validity of this particular diagnosis.
US Patients: 0.5-.0.8 (less than 1)% sometime in their lives
World Patients:
Sex Ratio: M;W+. More women in depressive; about even numbers in bipolar areas.
Age Onset: 30% between ages 25 and 35.
Brain Area: abnormal thoughts, unstable mood; psychotic symptoms for two weeks without any mood disorders. IT’s often misdiagnosed.
Symptoms: Bipolar has mania; hypomania and mixed episode vs. depressive only. May have hallucinations, delusions, disorganized speech and
Progression: thinking. May include audiotory hasllucinations.
Causes: Genetics under environmental stresses; age of the father at conception; pot and other substance abuses may be factors as well.
Medications: antipsychotics, mood stabilizers and antidepressants; electroconvulsive therapy for severe and resistant symptoms.
Therapies: Returning the patient to do the normal activities of life along with vocational rehabilitation.

CLICK HERE FOR THE FULL WIKIPEDIA ARTICLE.

Youtube Video:

Schizophrenia vs. Schizophreniform vs. Schizoid vs. Schizotypal

Amazon or Library Book: Schizoaffective Disorder

Click the book to link or order from Amazon.

Contact your local Social Security office for possible Disability Benefits through their Disability Determination Services,

Section 12.03.

4 CURRENT ARTICLES
FROM PUBMED

The world-wide medical research
reports chosen for each diagnosis

Clicking each title opens the
PubMed article’s summary-abstract.

Phelan-McDermid Syndrome-associated Psychosis: A Systematic Review
by Mark A Colijn on November 20, 2024
CONCLUSION: Psychotic presentations in Phelan-McDermid syndrome may qualitatively differ from schizophrenia. Although numerous antipsychotics may be efficacious in the treatment of Phelan-McDermid syndrome-associated psychosis, this review most importantly highlights the paucity of available high-quality evidence to guide treatment decisions in this respect, and as such indicates the need for more reports to be published.
Dynamics of recovery in psychosis, stigmatization, and microaggressions in mental healthcare: a qualitative study of service users' narratives
by Ploon Defourny on November 20, 2024
CONCLUSION: Our findings illustrate the gap between ideals concerning collaborative care relationships and the everyday experiences of service users. Service users often experienced an absence of relationship-building in mental healthcare, with negative consequences for their recovery process. Our identification of different forms of microaggression can raise awareness and effectuate behavioural change in professionals and contribute to the emancipation of people with psychosis.
Caregiving burden, depression, and anxiety in informal caregivers of people with mental illness in China: a cross-sectional survey
by Hao Yao on November 20, 2024
CONCLUSION: Informal caregivers of PwMI in China experienced a high level of caregiving burden, depression, and anxiety. Urgent actions are needed to relieve caregiving burden, depression, and anxiety among informal caregivers of PwMI in China.
Prevalence and Risk of Schizophrenia and Bipolar Disorder in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-analysis
by Sindhu Toomukuntla on November 20, 2024
CONCLUSION: With available studies, we could not provide convincing evidence for the hypothesis that the prevalence and risk of schizophrenia and related disorders and bipolar disorder are significantly greater in individuals with T1DM.